Do you suffer from burning, itchy or watery eyes? This study might be for you.

oGVHD and Dry Eye Study

oGVHD and Dry Eye StudyoGVHD and Dry Eye StudyoGVHD and Dry Eye Study

oGVHD and Dry Eye Study

oGVHD and Dry Eye StudyoGVHD and Dry Eye StudyoGVHD and Dry Eye Study
  • Home
  • Dry Eye Study
  • Am I A Candidate?
  • For Physicians
  • About Us
  • Contact Us
  • OSDI
  • More
    • Home
    • Dry Eye Study
    • Am I A Candidate?
    • For Physicians
    • About Us
    • Contact Us
    • OSDI
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Dry Eye Study
  • Am I A Candidate?
  • For Physicians
  • About Us
  • Contact Us
  • OSDI

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

WHat is Ocular graft-versus-host-disease?

Graft-versus-host-disease (GVHD) is a common condition that occurs after allogenic stem cell transplants that can cause symptoms such as skin rashes, nausea, vomiting, diarrhea, dry eyes, and other related conditions. A specific form of GVHD called Ocular GVHD (oGVHD) develops in "approximately 40-60% of patients" following a stem cell transplant and can lead to severe ocular surface disease which can diminish the patient's quality of life and restrict daily activities (Nassiri et al, 2013). 


Currently, the only treatment given to patients that present with oGVHD is artificial tears. Although effective in relieving symptoms in the short term, long term symptoms such as redness, pain, and irritation remain. This study aims to determine if medicated eye drops will be effective in reducing oGVHD symptoms. 

is this study safe and beneficial for patients

Yes, the study is safe. The drug we will be using is FDA approved for ocular use in dry eye patients. The study goal is to determine if it helps this more targeted population. As these patients tend to suffer greatly from dry eye symptoms, it could be highly beneficial for them to be a part of this study.  

HOW OGVHD IS DIAGNOSED

For the purposes of this study, oGVHD will be diagnosed using the NIH Consensus Development Project (Filipovich et al. 2005) and the International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group (Ogawa et al. 2013). A series of tests including the Ocular Surface Disease Index (OSDI), conjunctival injection, Schirmer's 1 tear test, corneal Flourescein staining, and a lid margin exam will determine if a patient meets the criteria for oGVHD. 


Copyright © 2022 oGVHD and Dry Eye Study, Houston - All Rights Reserved.


Powered by Woodallen.com

Currently Enrolling

If you suffer from dry eye, you may benefit

learnMore

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept